Orthomyxoviridae

Susceptibility
Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen
Simon J. F. Macdonald, Keith G. Watson, Rachel Cameron, David K. Chalmers, Derek A. Demaine, Rob J. Fenton, David Gower, J. Nicole Hamblin, Stephanie Hamilton, Graham J. Hart, Graham G. A. Inglis, Betty Jin, Haydn T. Jones, Darryl B. McConnell, Andy M. Mason, Van Nguyen, Ian J. Owens, Nigel Parry, Phillip A. Reece, Stephen E. Shanahan, Donna Smith, Wen-Yang Wu, Simon P. Tucker
Antiviral Agents
Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin
Barry R. O'Keefe, Donald F. Smee, Jim A. Turpin, Carrie J. Saucedo, Kirk R. Gustafson, Toshiyuki Mori, Dennis Blakeslee, Robert Buckheit, Michael R. Boyd
Antiviral Agents
Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir
J. McKimm-Breschkin, T. Trivedi, A. Hampson, A. Hay, A. Klimov, M. Tashiro, F. Hayden, M. Zambon
Antiviral Agents
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
Y. Furuta, K. Takahashi, Y. Fukuda, M. Kuno, T. Kamiyama, K. Kozaki, N. Nomura, H. Egawa, S. Minami, Y. Watanabe, H. Narita, K. Shiraki
Antiviral Agents
Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants
Larisa V. Gubareva, Robert G. Webster, Frederick G. Hayden
Antiviral Agents
Novel α- and β-Amino Acid Inhibitors of Influenza Virus Neuraminidase
Warren M. Kati, Debra Montgomery, Clarence Maring, Vincent S. Stoll, Vincent Giranda, Xiaoqi Chen, W. Graeme Laver, William Kohlbrenner, Daniel W. Norbeck
Antiviral Agents
Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir
S. Bantia, C. D. Parker, S. L. Ananth, L. L. Horn, K. Andries, P. Chand, P. L. Kotian, A. Dehghani, Y. El-Kattan, T. Lin, T. L. Hutchison, J. A. Montgomery, D. L. Kellog, Y. S. Babu
Antiviral Agents
Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies
J. M. Barnett, A. Cadman, D. Gor, M. Dempsey, M. Walters, A. Candlin, M. Tisdale, P. J. Morley, I. J. Owens, R. J. Fenton, A. P. Lewis, E. C. J. Claas, G. F. Rimmelzwaan, R. De Groot, A. D. M. E. Osterhaus
Antiviral Agents
Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
Weixing Li, Paul A. Escarpe, Eugene J. Eisenberg, Kenneth C. Cundy, Clive Sweet, Kenneth J. Jakeman, James Merson, Willard Lew, Matt Williams, Lijun Zhang, Choung U. Kim, Norbert Bischofberger, Ming S. Chen, Dirk B. Mendel

Main menu

User menu

Search

Orthomyxoviridae

Pages